Skip to main content
Funded Studies

Michael A. Schwarzschild, MD, PhD

Professor at Massachusetts General Hospital

Location: Boston, MA United States

Michael A. Schwarzschild, MD, PhD, is a neurologist at Massachusetts General Hospital and Julieanne Dorn Professor of Neurology at Harvard Medical School. He pursued doctoral studies on tyrosine hydroxylase neurochemistry at HMS and then neurology residency and Parkinson’s disease fellowship training at MGH. He has developed a translational research program focusing on purines like adenosine, caffeine and urate, and on gene (e.g., LRRK2)-environment interactions in animal models and clinical studies of PD. He directs the Molecular Neurobiology Lab at the MassGeneral Institute for Neurodegenerative Disease where his interdisciplinary research program spans the neurobiology, epidemiology and clinical science of Parkinson’s.

In 2018 he was elected to a second six-year term leading the Parkinson Study Group (PSG), a consortium of North American clinical trial sites and investigators dedicated to finding improved treatments for people with Parkinson’s. At MGH he cares for patients with PD and their families in a weekly movement disorders clinic.


Associated Grants

  • From Cancer Associations to Altered Immunity in the Pathogenesis of Parkinson’s Disease

    2020


  • Purine Biomarkers of LRRK2-Associated Parkinson's Disease

    2018


  • Purine Biomarkers of LRRK2 PD

    2014


  • Inosine for Parkinson's Disease: Safety and Trial Design Optimization

    2007


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.